Beta-blocker therapy in unstable severe heart failure, evidence or experience?
Authors:
- 13 December 2012
- journal article
- point of-view
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 21 (1) , 3-5
Abstract
Currently, no evidence exists on the effects of beta-receptor blocker (BRB) treatment in patients with unstable severe heart failure. When confronted with this specific patient category, clinical experience in our centre has consistently guided us to lower the dose or stop BRB therapy. To share this experience, we present three clinical case scenarios and discuss background literature motivating our approach in these patients.Keywords
This publication has 21 references indexed in Scilit:
- Percutaneous left ventricular partitioning device for chronic heart failureNetherlands Heart Journal, 2012
- Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapyNetherlands Heart Journal, 2012
- Preexisting heart failure is an underestimated risk factor in cardiac surgeryNetherlands Heart Journal, 2012
- Treatment options in end-stage heart failure: where to go from here?Netherlands Heart Journal, 2011
- Cardiac resynchronisation improves survival in mild heart failure!Netherlands Heart Journal, 2011
- Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failureHeart, 2003
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failureJACC, 1992
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975